Treace Medical Concepts Inc (TMCI)
4.78
+0.12
(+2.58%)
USD |
NASDAQ |
Nov 01, 16:00
4.775
0.00 (0.00%)
After-Hours: 20:00
Treace Medical Concepts Revenue (Quarterly): 44.46M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 44.46M |
| March 31, 2024 | 51.11M |
| December 31, 2023 | 62.21M |
| September 30, 2023 | 40.76M |
| June 30, 2023 | 41.95M |
| March 31, 2023 | 42.20M |
| December 31, 2022 | 49.77M |
| September 30, 2022 | 33.06M |
| June 30, 2022 | 29.97M |
| Date | Value |
|---|---|
| March 31, 2022 | 29.05M |
| December 31, 2021 | 33.44M |
| September 30, 2021 | 21.62M |
| June 30, 2021 | 20.65M |
| March 31, 2021 | 18.71M |
| December 31, 2020 | 24.10M |
| September 30, 2020 | 14.27M |
| June 30, 2020 | 7.739M |
| March 31, 2020 | 11.26M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
7.739M
Minimum
Jun 2020
62.21M
Maximum
Dec 2023
32.02M
Average
31.51M
Median
Revenue (Quarterly) Benchmarks
| Stryker Corp | 5.494B |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 6.029M |
| Xtant Medical Holdings Inc | 29.94M |
| Catheter Precision Inc | 0.093M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.21M |
| Total Expenses (Quarterly) | 65.84M |
| EPS Diluted (Quarterly) | -0.34 |
| Enterprise Value | 255.38M |
| Gross Profit Margin (Quarterly) | 80.25% |
| Profit Margin (Quarterly) | -47.70% |
| Earnings Yield | -21.39% |
| Normalized Earnings Yield | -21.39 |